about
Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replicationRalstonia eutropha H16 encodes two and possibly three intracellular Poly[D-(-)-3-hydroxybutyrate] depolymerase genesSimultaneous absolute quantification of target and control templates by real-time fluorescence reverse transcription-PCR using 4-(4'-dimethylaminophenylazo)benzoic acid as a dark quencher dye.Hepatitis B virus-induced oncogenesis.Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyMultifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.Host cell kinases and the hepatitis C virus life cycle.Claudins and pathogenesis of viral infection.PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation.miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods.Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymeraseFunctional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR.Cholesterol uptake and hepatitis C virus entry.Interferon-lambda polymorphisms and hepatitis C virus clearance revisited.A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.Viral manipulation of STAT3: Evade, exploit, and injure.Oncogenic Signaling Induced by HCV InfectionBeyond viral dependence: The pathological consequences of HCV-induced EGF signalingCombined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentFluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias[Open Sesame: regulation of hepatitis C virus entry into hepatocytes]Rewiring Host Signaling: Hepatitis C Virus in Liver PathogenesisHCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseHepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its GripA genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
P50
Q24300700-371DA716-D9DF-411D-9C27-436BA19E51C0Q31147026-A7030642-6C03-4105-8010-6FD691DB9615Q32129925-3F15D86F-3472-4B5F-83EB-F6282F15BB89Q33787553-DE8C0B60-FF9B-4BDE-9053-F03DC6BBCC7DQ35602284-9F1782BB-2BC9-43C9-BD59-710F9D8B0F58Q37086640-A7807D6D-3260-4A30-A1B4-87D262F19B85Q37611842-CD4910E7-5BCF-4A8B-B9C0-E03636D6997EQ38049925-71A2BFED-2054-4218-BFCD-E43D50064232Q38431985-79601890-AA79-467C-BB7F-B3DDFBD717F8Q38470874-0672194E-B8EC-4CA1-87B0-4B985D669998Q38839303-0E2B193E-68FD-4EE1-9320-D02CC0A3FD9FQ38979938-348063F0-A99F-4C16-9701-AA291B319DBBQ39177270-05ADDB07-D747-465B-84B8-6768F04EE79BQ39762742-284FCB7B-A0CE-4077-960B-5AFA5CFB586BQ40249538-5C7FF2DF-12C2-4C28-B144-BE413766A4D5Q42150362-2C73849F-7A7B-4F0D-907F-B12C3DC233D9Q42283120-EC9E5EC6-9A83-471B-B8A6-6814A6730A2FQ42990165-176C1C7C-03A5-496F-98CE-4AF7BEDCF77CQ43989560-EC54BE5E-92EB-4197-ADF2-C00DE803C4CBQ44082928-946AE46E-2BDF-4953-BC74-45D9BC0CB6AAQ45351788-A4F78EF4-91CD-4745-A0F8-27AC72D1220CQ45422062-EA4A1D83-D948-4C75-88C5-B724922DD292Q54255379-5AA66292-E677-489E-815E-4B7BDB2B2F12Q57050806-76D162BF-CC30-4FFA-8824-47F0FB17CC32Q59358228-BE59FE77-3E27-4F32-A1A6-0FB47D006B72Q64111271-070D02E3-F40A-4C55-A8AF-886305854777Q74445774-484CB8A9-5F7B-42BC-8EB3-70A64CBB0961Q82746885-F554F4E6-3F7D-4B4C-AF85-8CEB85F19F2BQ90001277-BA119627-7727-40C0-AF3A-836A656C42E7Q92142728-4E49F313-86AD-4F38-BE87-091706157E01Q94480541-0F827911-BB9C-4AA1-A56E-B80A7706FE4BQ96126330-1C5DD08E-094A-4793-BD88-6EA53EEE1272
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joachim Lupberger
@ast
Joachim Lupberger
@en
Joachim Lupberger
@es
Joachim Lupberger
@nl
type
label
Joachim Lupberger
@ast
Joachim Lupberger
@en
Joachim Lupberger
@es
Joachim Lupberger
@nl
prefLabel
Joachim Lupberger
@ast
Joachim Lupberger
@en
Joachim Lupberger
@es
Joachim Lupberger
@nl
P106
P31
P496
0000-0003-3996-3907